Gibson Dunn has advised Serapha Bio, Inc. Latham & Watkins has advised Boundless Bio, Inc. Serapha Bio, Inc., a privately held biotechnology company, and Boundless Bio,...
Serapha Bio and Boundless Bio Announce Merger and $230 Million Private Placement
Mobia Medical Raises $150 Million in Initial Public Offering
Latham & Watkins LLP has advised Mobia Medical, Inc. Cleary Gottlieb has represented the underwriters. Mobia Medical, Inc., a commercial-stage medical device company, completed its initial...
CapVest Recapitalizes Curium at $7 Billion Valuation Through Continuation Vehicle
Clifford Chance has advised ICG Strategic Equity as lead investor. Kirkland & Ellis has advised CapVest Partners. CapVest Partners has announced the recapitalization of Curium, a...
Crystalys Therapeutics Launches With $205 Million Series A Financing to Advance Gout Treatment
Latham & Watkins has advised Crystalys Therapeutics. Wilson Sonsini Goodrich & Rosati has advised Novo Holdings and SR One. Crystalys Therapeutics Inc., a clinical-stage biopharmaceutical company,...
Stratify Aerospace’s Acquisition Of Metron Aviation From Airbus
Clifford Chance advised Airbus on the deal. Stratify Aerospace, LLC (Stratify) announced the acquisition of Metron Aviation, Inc. (Metron Aviation) from Airbus. Stratify Aerospace is a...
Alcon Inc’s Acquisition of LENSAR Inc
Norton Rose Fulbright represented Alcon Inc., Latham & Watkins represented LENSAR, Inc. in the transaction. Alcon Inc. (SIX/NYSE: ALC), the global leader in eye care dedicated...
Keymed Biosciences’ Licensing Agreement With Ouro Medicines LLC
Clifford Chance advised Keymed Biosciences on the deal. Keymed Biosciences (HKSe: 02162) signed a licensing agreement granting Platina the exclusive worldwide rights to develop, manufacture and...
Keymed Biosiences’ Out-Licensing Transaction With Timberlyne Therapeutics Inc.
Clifford Chance advised Keymed Biosciences on the deal. Timberlyne Therapeutics, Inc. announced its US$180 million Series A financing to advance the development of CM313. Investors Abingworth,...
Charme Capital Partners’ Acquisition Of Centogene GmbH
Clifford Chance advised Charme Capital Partners on the deal. Charme Capital Partners, a pan-European private equity firm, announced the acquisition of Centogene GmbH, a rare diseases...
Almaviva S.p.A.’s Bond Offering To Financing The Acquisition Of Iteris, Inc.
Legance, Linklaters, King & Spalding, EY SLT and Machado, Meyer, Sendacz e Opice advised Almaviva, while Latham & Watkins advised Iteris. PedersoliGattai, Milbank and TozziniFreire advised...
LetsGetChecked’s Acquisition of Truepill
Goodwin Procter, McDermott Will & Emery, and Mason Hayes & Curran advised LetsGetChecked, while Latham & Watkins and BakerHostetler advised Truepill on the deal. LetsGetChecked, a...
Viking Global Investors’ Acquisition Of Minority Stake In Humaneva
Clifford Chance advised Viking Global Investors on the deal. Viking Global Investors (Viking), a global investment firm based in the United States, acquired a significant minority...